Infections Clinical Trial
Official title:
Implementation of an Infusion Management Scheme to Improve Patient Outcome in Tertiary Children's Hospitals:A Multi-center Before-afer Trial
This study is a multi-center before-after trial design. The object is to observe whether the incidence of central line associated blood stream infection(CLABSI) will tend to descend compared with retrospective electronic medical record data after implementation of an infusion management scheme which comes form " Clinical Practice Guideline on Infusion Therapy in Children " .
| Status | Recruiting |
| Enrollment | 12568 |
| Est. completion date | August 7, 2024 |
| Est. primary completion date | August 7, 2024 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 1 Day to 18 Years |
| Eligibility | Inclusion Criteria for centers: - A tertiary children's hospital with more than 300 beds - The vice president in charge of nursing affairs, the director of nursing department and the director of hospital infection control department all agree in participating in this study with written permission, which include total acceptance of infusion management scheme and outcome indicators report as required - To obtain the approval from Ethics Committee of the hospital Inclusion Criteria for patients: - Hospitalized children aged 0~18 years - Catheterization and maintenance in the same center - The indwelling time is longer than 48h Exclusion Criteria: - The vice president in charge of nursing affairs or the director of nursing department inform the researcher to withdraw from this study with written form and should clear reasons - The number of cases for suspected CLABSI sample actually submitted for inspection / The number of cases for suspected CLABSI sample should submitted for inspection<0.9 - The awareness rate of infusion management scheme in clinical nurses is less than 90% and the qualification rate of the practice examination in clinical nurses is less than90% during inspection |
| Country | Name | City | State |
|---|---|---|---|
| China | Hunan Children's Hospital | Changsha | Hunan |
| China | Chengdu Women's and Children's Central Hospital | Chengdu | Sichuan |
| China | Dalian women and children's medical group | Dalian | Liaoning |
| China | Anhui Provincial Children's Hospital | Hefei | Anhui |
| China | First Affiliated Hospital of Guangxi Medical University | Nanning | Guangxi |
| China | Qidong Women's and Children's Health | Qidong | Jiangsu |
| China | Children's Hospital of Fudan University | Shanghai | Shanghai |
| China | Tongji Hospital | Wuhan | Hubei |
| China | Xiamen Children's Hospital | Xiamen | Fujian |
| Lead Sponsor | Collaborator |
|---|---|
| Children's Hospital of Fudan University | Anhui Provincial Children's Hospital, Chengdu Women's and Children's Central Hospital, Dalian women and children's medical group, First Affiliated Hospital of Guangxi Medical University, Hunan Children's Hospital, Qidong Women's and Children's Health, Tongji Hospital, Xiamen Children's Hospital |
China,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Incidence of CLABSI | CLABSI diagnostic criteria requires that a central line is in situ at the time of or within 48 hours; children with a central line have fever (over 38?), chills, hypotension or mental state changes; there is no alternate source of bloodstream infection. Apart from the above three necessary requirements, CLABSI diagnosis could be accompanied by two positive blood cultures drawn from a peripheral vein and a CVAD, two positive blood cultures drawn from different CVADs, one positive blood culture from a CVAD with a planned specific antimicrobial therapy or common skin contamination bacteria cultured (eg. Coagulase-negative Staphylococci, diphtheroids, Bacillus or Micrococcus).
Incidence of CLABSI = (case numbers of CLABSI)/(Catheter Days per Month)×1000‰. |
During the 6-month implementation | |
| Secondary | Changes of Inspection rate of suspected CLABSI samples | When there are suspected cases of CLABSI, the physician will prescribe blood culture and the nurse will draw blood within 1 hour and send them for inspection (if antibiotics are needed, blood should be drawn before administration).
Suspected CLABSI samples inspection rate= (documented samples for inspection )/(Required samples for inspection)×100%. |
From baseline to the end of the 6-month implementation | |
| Secondary | Incidece of infiltration (of Grade2 or higher) and/or extravasation | Incidence of infiltration (of Grade2 or higher) and extravasation: The bedside nurses document PIV infiltration and extravasation using "Pediatric PIV Infiltration Scale" during fluid infusing and every shift.
Incidence of infiltration (of Grade2 or higher) and/or extravasation = (case numbers of infiltration (of Grade2 or higher) and/or extravasation)/(Catheter Days per Month)×1000‰. |
During the 6-month implementation | |
| Secondary | Changes of the scores of readiness of internal context | 10% of nurses in every participant center will be randomly drawn to complete the investigation questionnaire for the readiness of internal context using self-made "Assessment Tool of Organizational Internal Context (6 items) " and "Assessment Tool of Local Internal Context ( 9 items)".The purpose of the survey is to evaluate the internal context of evidence-based practice in each participant center. The score of each item is based on Likert 5 grades rating levels from 1 (lowest) to 5 (highest). | From baseline to the end of the 6-month implementation |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06055777 -
Study of the Safety, Tolerability, and PK of SZEY-2108 Administered Intravenously to HVs in SAD and MAD Cohorts
|
Phase 1 | |
| Recruiting |
NCT05578196 -
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
|
N/A | |
| Recruiting |
NCT05793983 -
S100A8/A9 and Innate Immunity in Liver Disease
|
||
| Active, not recruiting |
NCT05963269 -
The Effect of the Game on Students' Intramuscular Injection Skills
|
N/A | |
| Not yet recruiting |
NCT06026852 -
Validation of Betalactam ML Prediction Models - TDMAide
|
N/A | |
| Not yet recruiting |
NCT02222779 -
Quantification of Transition Metals
|
N/A | |
| Completed |
NCT01976234 -
Stored RBC Transfusion and Immonomodulation
|
N/A | |
| Completed |
NCT02345135 -
Susceptibility to Infections in Ataxia Telangiectasia
|
N/A | |
| Completed |
NCT01530763 -
Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)
|
Phase 2/Phase 3 | |
| Completed |
NCT01158560 -
A Trial of Vitamin D and Health Advice for the Prevention of Upper Respiratory Tract Infections
|
Phase 3 | |
| Completed |
NCT01176786 -
Reusable Versus Disposable Draping System in Breast Reconstruction Surgery
|
N/A | |
| Active, not recruiting |
NCT05284097 -
Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study
|
Phase 2 | |
| Enrolling by invitation |
NCT06055712 -
Antibiotic Prophylaxis in Pediatric Open Fractures
|
Phase 4 | |
| Not yet recruiting |
NCT06338345 -
Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients
|
N/A | |
| Not yet recruiting |
NCT06402292 -
Surgical Treatment of Osteoarticular Infections Using Bioactive Bone Substitute
|
N/A | |
| Recruiting |
NCT06002685 -
Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention
|
N/A | |
| Completed |
NCT02802059 -
E. Coli Nissle 1917 - Suspension for Infection Prophylaxis
|
Phase 3 | |
| Completed |
NCT05289674 -
The Effect of Lactoferrin in High Calorie Formula on IL-6 and IL10 in Children With Failure to Thrive and Infection
|
N/A | |
| Recruiting |
NCT05770765 -
Creation of a Bank of Biological Materials and Associated Data Related to Patients With Infectious and Tropical Diseases
|
||
| Completed |
NCT05389540 -
Rural South and Southeast Asia Household Health Survey
|